Brand  (β version)

PDB ID: 4ZZX

Hetero Atom Contents

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
FSU 2-(3-methoxypropyl)-3-oxo-2,3-dihydro-1h-isoindole-4-carboxamide PoSSuM
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show

Structure summary

Code : 4ZZX   PDBj   RCSB PDB   PDBe
Header : TRANSFERASE
Title : Structure of PARP2 catalytic domain bound to an isoindolinone inhibitor
Release Data : 2015-08-12
Compound :
mol_id molecule chains synonym
1 POLY [ADP-RIBOSE] POLYMERASE 2 A,B PARP-2, HPARP-2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 2, ARTD2, NAD(+) ADP-RIBOSYLTRANSFERASE 2, ADPRT-2, POLYADP-RIBOSE SYNTHASE 2, PADPRT-2, PARP-2, HPARP-2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 2, ARTD2, NAD(+) ADP-RIBOSYLTRANSFERASE 2, A DPRT-2, POLYADP-RIBOSE SYNTHASE 2, PADPRT-2, POLY ADP-RIBOSE POLYMERASE 2, POLY ADP-RIBOSE POLYMERASE 2
ec: 2.4.2.30
fragment: CATALYTIC DOMAIN, UNP RESIDUES 223-583
Source :
mol_id organism_scientific organism_common expression_system
1 HOMO SAPIENS  (taxid:9606) HUMAN ESCHERICHIA COLI  (taxid:511693)
expression_system_strain: BL21
expression_system_vector_type: PLASMID
expression_system_plasmid: PET28A
Authors : Casale, E., Fasolini, M., Papeo, G., Posteri, H., Borghi, D., Busel, A.A., Caprera, F., Ciomei, M., Cirla, A., Corti, E., DAnello, M., Fasolini, M., Felder, E.R., Forte, B., Galvani, A., Isacchi, A., Khvat, A., Krasavin, M.Y., Lupi, R., Orsini, P., Perego, R., Pesenti, E., Pezzetta, D., Rainoldi, S., RiccardiSirtori, F., Scolaro, A., Sola, F., Zuccotto, F., Donati, D., Montagnoli, A.
Keywords : TRANSFERASE
Exp. method : X-RAY DIFFRACTION ( 1.65 Å )
Citation :

Discovery of 2-[1-(4,4-Difluorocyclohexyl)Piperidin-4-Yl]-6-Fluoro-3-Oxo-2,3-Dihydro-1H-Isoindole-4-Carboxamide (Nms-P118): A Potent, Orally Available and Highly Selective Parp- 1 Inhibitor for Cancer Therapy.

Papeo, G.M.E.,Posteri, H.,Borghi, D.  et al.
(2015)  J.Med.Chem.  58 : 6875

PubMed: 26222319
DOI: 10.1021/ACS.JMEDCHEM.5B00680

Reaction

Chain : A, B
UniProt : Q9UGN5 (PARP2_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
NAD(+) + (ADP-D-ribosyl)n-acceptor = nicotinamide + (ADP-D- ribosyl)n+1-acceptor + H(+). 2.4.2.30 PubMed:25043379, PubMed:30104678, PubMed:30321391, PubMed:32939087
-
L-seryl-[protein] + NAD(+) = H(+) + nicotinamide + O-(ADP-D- ribosyl)-L-seryl-[protein] - PubMed:32028527, PubMed:32939087, PubMed:34108479, PubMed:28190768
left-to-right PubMed:32028527, PubMed:32939087, PubMed:34108479, PubMed:28190768
L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L- aspartyl-[protein] + nicotinamide - PubMed:25043379
left-to-right
L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L- glutamyl-[protein] + nicotinamide - PubMed:25043379
left-to-right